Perrigo (PRGO) Revenue Growth (5y) (2017 - 2026)
Perrigo (PRGO) Revenue Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.88 Bn | 87.01 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.31 Bn | 30.37 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.92 Bn | 16.61 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Perrigo | 1.44 Bn | 1.09 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -0.82% |
| Dec 31, 2025 | -2.96% |
| Sep 27, 2025 | 0.79% |
| Jun 28, 2025 | 2.17% |
| Mar 29, 2025 | -0.74% |
| Dec 31, 2024 | -2.96% |
| Sep 28, 2024 | -1.80% |
| Jun 29, 2024 | -1.50% |
| Mar 30, 2024 | -1.63% |
| Dec 31, 2023 | -0.65% |
| Sep 30, 2023 | -0.16% |
| Jul 1, 2023 | 0.11% |
| Apr 1, 2023 | -0.59% |
| Dec 31, 2022 | -2.07% |
| Oct 1, 2022 | -2.23% |
| Jul 2, 2022 | -1.95% |
| Apr 2, 2022 | -2.09% |
| Dec 31, 2021 | -3.66% |
| Oct 2, 2021 | -3.74% |
| Apr 3, 2021 | -5.60% |